Collectively, the results of the present study highlighted that Bag‐1 overexpression in HER2+ breast cancer cells, specifically BT‐474 cells, may regulate the expression of HSPs through promoting HSF1 phosphorylation at Ser326, through the PI3K/AKT/mTOR pathway. Here, ERBB2 is linked to breast carcinoma.